Parkman Healthcare Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.7M | Buy |
251,741
+50,922
| +25% | +$3.98M | 2.26% | 14 |
|
|
2025
Q1 | $14.6M | Buy |
200,819
+55,605
| +38% | +$4.03M | 1.73% | 22 |
|
|
2024
Q4 | $10.8M | Buy |
+145,214
| New | +$10.8M | 1.43% | 25 |
|
|
2023
Q4 | – | Sell |
-40,000
| Closed | -$2.77M | – | 97 |
|
|
2023
Q3 | $2.77M | Buy |
+40,000
| New | +$2.77M | 0.51% | 59 |
|
|
2023
Q1 | – | Sell |
-54,579
| Closed | -$4.07M | – | 87 |
|
|
2022
Q4 | $4.07M | Sell |
54,579
-27,327
| -33% | -$2.04M | 1.08% | 38 |
|
|
2022
Q3 | $6.77M | Buy |
+81,906
| New | +$6.77M | 1.92% | 18 |
|
|
2021
Q1 | – | Sell |
-50,584
| Closed | -$4.62M | – | 88 |
|
|
2020
Q4 | $4.62M | Sell |
50,584
-71,947
| -59% | -$6.56M | 1.18% | 33 |
|
|
2020
Q3 | $9.78M | Buy |
122,531
+2,531
| +2% | +$202K | 2.59% | 8 |
|
|
2020
Q2 | $8.29M | Buy |
+120,000
| New | +$8.29M | 2.34% | 11 |
|